CIRCUMVENT G2 has withstood the toughest test there is. TIME.
CIRCUMVENT G2 vaccines from Merck Animal Health provide the monumental protection herds need in the ever-evolving fight against circovirus.
Protect your pigs, protect your bottom line.
Porcine circovirus type 2 (PVC2) is one of the top-three economically significant swine diseases. If a herd is left unvaccinated against PCV2, losses could be up to $20 per pig.1
1Gillespie J, et al. Porcine circovirus type 2 and porcine circovirus-associated disease. J Vet Intern Med. 2009;23:1151-1163.
Protecting against PCV2 can help protect the bottom line by:
IMPROVING FEED EFFICIENCY
PROVIDING A LONG DURATION OF IMMUNITY (DOI)
INCREASING FEED SAVINGS
REDUCING LATE-FINISHING MORTALITY
For more information, download the comprehensive CIRCUMVENT G2 detailer.
Protection you can trust.
For more than a decade, CIRCUMVENT G2 vaccines have been effective in mitigating the damaging effects of PCV2. CIRCUMVENT PCV G2 and CIRCUMVENT PCV-M G2 are evolutions of the original vaccine, building on the same protection you’ve come to rely on.
CIRCUMVENT G2 vaccines aid in the prevention of PCV2 viremia.
Here’s why it matters.
Following exposure to the virus, PCV2 viremia starts building and circulating in the blood. It’s the initial step in disease development within the pig, but it can last up to four or five months post-infection. Preventing it early helps to limit or eliminate infection.
In addition to negatively impacting average daily gain and feed efficiency, PCV2 viremia also:
• Prolongs virus shedding and increases the risk to other pigs
• Increases the risk of coinfection from PRRSV, Mycoplasma hyopneumoniae and influenza
When it comes to selecting a PCV2 vaccine, it’s easy to see why choosing a solution proven to aid in viremia prevention is crucial.
CIRCUMVENT PCV G2 significantly reduces virus shedding.
In a study demonstrating its 5-month DOI, CIRCUMVENT PCV G2 greatly reduced virus shedding in pigs during the entire post-challenge monitoring period following a PCV2 and PRRSV challenge 20 weeks after vaccination.
More veterinarians rely on CIRCUMVENT G2.
Since 2017, CIRCUMVENT G2 has held the majority of the market share.
The rigorous development and testing of these vaccines is just one more reason why more veterinarians choose to put their trust in CIRCUMVENT G2.
MORE THAN 1 BILLION PIGS VACCINATED WORLDWIDE.
See all the reasons why CIRCUMVENT G2 is the trusted choice.
See the rest of the Merck Animal Health
swine vaccine lineup.